BioTelemetry, Inc. (BEAT): Price and Financial Metrics
BioTelemetry, Inc. (BEAT)
Today's Latest Price: $46.59 USD
Updated Dec 5 11:32am
Add BEAT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 55 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
BEAT Stock Summary
- With a price/earnings ratio of 30.09, Biotelemetry Inc P/E ratio is greater than that of about 72.55% of stocks in our set with positive earnings.
- In terms of twelve month growth in earnings before interest and taxes, Biotelemetry Inc is reporting a growth rate of 404.73%; that's higher than 96.91% of US stocks.
- The volatility of Biotelemetry Inc's share price is greater than that of 73.9% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to Biotelemetry Inc are FONR, IRMD, MLAB, FNKO, and OPY.
- Visit BEAT's SEC page to see the company's official filings. To visit the company's web site, go to www.gobio.com.
BEAT Stock Price Chart More Charts
BEAT Price/Volume Stats
| Current price | $46.59 |
| Prev. close | $46.65 |
| Day low | $46.23 |
| Day high | $46.90 |
| 50-day MA | $42.09 |
| 200-day MA | $49.08 |
| 52-week high | $80.92 |
| 52-week low | $37.07 |
| Volume | 34,389 |
| Avg. volume | 445,519 |
| Dividend yield | N/A |
| Market Cap | 1.58B |
BioTelemetry, Inc. (BEAT) Company Bio
BioTelemetry Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It operates in three segments: Patient Services, Product, and Research Services. The company is based in Malvern, Pennsylvania.
Top Stories View All
Best & Worst Performing Stock Industries for December 4, 2019
Best & Worst Performing Small Cap Stocks for December 4, 2019
Best & Worst Performing Mid Cap Stocks for December 4, 2019
Best & Worst Performing Large Cap Stocks for December 4, 2019
Best & Worst Performing Mega Cap Stocks for December 4, 2019
View All Top Stories
Loading social stream, please wait...